745 related articles for article (PubMed ID: 23660416)
1. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.
Bravi F; Bosetti C; Tavani A; Gallus S; La Vecchia C
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1413-1421.e1. PubMed ID: 23660416
[TBL] [Abstract][Full Text] [Related]
2. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.
Inoue M; Yoshimi I; Sobue T; Tsugane S;
J Natl Cancer Inst; 2005 Feb; 97(4):293-300. PubMed ID: 15713964
[TBL] [Abstract][Full Text] [Related]
3. Coffee consumption and risk of liver cancer: a meta-analysis.
Larsson SC; Wolk A
Gastroenterology; 2007 May; 132(5):1740-5. PubMed ID: 17484871
[TBL] [Abstract][Full Text] [Related]
4. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis.
Bravi F; Bosetti C; Tavani A; Bagnardi V; Gallus S; Negri E; Franceschi S; La Vecchia C
Hepatology; 2007 Aug; 46(2):430-5. PubMed ID: 17580359
[TBL] [Abstract][Full Text] [Related]
5. The effect of coffee consumption on the development of hepatocellular carcinoma in hepatitis B virus endemic area.
Jang ES; Jeong SH; Lee SH; Hwang SH; Ahn SY; Lee J; Park YS; Hwang JH; Kim JW; Kim N; Lee DH; Kim HY
Liver Int; 2013 Aug; 33(7):1092-9. PubMed ID: 23651110
[TBL] [Abstract][Full Text] [Related]
6. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.
Kennedy OJ; Roderick P; Buchanan R; Fallowfield JA; Hayes PC; Parkes J
BMJ Open; 2017 May; 7(5):e013739. PubMed ID: 28490552
[TBL] [Abstract][Full Text] [Related]
7. Inverse Association of Coffee with Liver Cancer Development: An Updated Systematic Review and Meta-analysis.
Bhurwal A; Rattan P; Yoshitake S; Pioppo L; Reja D; Dellatore P; Rustgi V
J Gastrointestin Liver Dis; 2020 Sep; 29(3):421-428. PubMed ID: 32830818
[TBL] [Abstract][Full Text] [Related]
8. Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies.
Bravi F; Tavani A; Bosetti C; Boffetta P; La Vecchia C
Eur J Cancer Prev; 2017 Sep; 26(5):368-377. PubMed ID: 27111112
[TBL] [Abstract][Full Text] [Related]
9. Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis.
Yang Y; Zhang D; Feng N; Chen G; Liu J; Chen G; Zhu Y
Gastroenterology; 2014 Nov; 147(5):1031-42. PubMed ID: 25127680
[TBL] [Abstract][Full Text] [Related]
10. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy.
Montella M; Polesel J; La Vecchia C; Dal Maso L; Crispo A; Crovatto M; Casarin P; Izzo F; Tommasi LG; Talamini R; Franceschi S
Int J Cancer; 2007 Apr; 120(7):1555-9. PubMed ID: 17205531
[TBL] [Abstract][Full Text] [Related]
11. Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis C: analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial.
Yu L; Morishima C; Ioannou GN
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1661-6.e1-3. PubMed ID: 23707779
[TBL] [Abstract][Full Text] [Related]
12. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan.
Tanaka K; Hara M; Sakamoto T; Higaki Y; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S
Cancer Sci; 2007 Feb; 98(2):214-8. PubMed ID: 17233838
[TBL] [Abstract][Full Text] [Related]
13. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis.
Shi Y; Wu YH; Wu W; Zhang WJ; Yang J; Chen Z
Liver Int; 2012 Feb; 32(2):231-40. PubMed ID: 21745272
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study.
Donato F; Tagger A; Chiesa R; Ribero ML; Tomasoni V; Fasola M; Gelatti U; Portera G; Boffetta P; Nardi G
Hepatology; 1997 Sep; 26(3):579-84. PubMed ID: 9303486
[TBL] [Abstract][Full Text] [Related]
15. Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study.
Leung WW; Ho SC; Chan HL; Wong V; Yeo W; Mok TS
J Epidemiol Community Health; 2011 Jun; 65(6):556-8. PubMed ID: 20693491
[TBL] [Abstract][Full Text] [Related]
16. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
17. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
[TBL] [Abstract][Full Text] [Related]
19. Family history of liver cancer and hepatocellular carcinoma.
Turati F; Edefonti V; Talamini R; Ferraroni M; Malvezzi M; Bravi F; Franceschi S; Montella M; Polesel J; Zucchetto A; La Vecchia C; Negri E; Decarli A
Hepatology; 2012 May; 55(5):1416-25. PubMed ID: 22095619
[TBL] [Abstract][Full Text] [Related]
20. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study.
Gelatti U; Covolo L; Franceschini M; Pirali F; Tagger A; Ribero ML; Trevisi P; Martelli C; Nardi G; Donato F;
J Hepatol; 2005 Apr; 42(4):528-34. PubMed ID: 15868652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
